Share to

Overview

Specs

Technical Documents

Articles

reviews

Consult

returns

Product introduction

GDC-0152是一种有效的XIAP-BIR3，ML-IAP-BIR3，cIAP1-BIR3和cIAP2-BIR3拮抗剂，无细胞试验中Ki分别为28 nM，14 nM，17 nM和43 nM，对cIAP1-BIR2和cIAP2-BIR2具较低亲和力。Phase 1。 GDC-0152是有效的小分子凋亡蛋白抑制因子（IAP ）拮抗剂，包括ML-IAP、XIAP、cIAP1和cIAP2，通过与ML-IAP的BIR结构域以及XIAP、cIAP1和cIAP2的BIR3结构域结合起到抑制作用，Ki值分别为14 nM、28 nM、17 nM和43 nM。GDC-0152通过促进cIAP1降解和诱导caspase-3/7激活，从而降低乳腺癌细胞的活力，而正常上皮细胞不受影响，进而有效抑制乳腺癌肿瘤的生长。近期研究表明，在HEK293T细胞中，GDC-0152通过干扰XIAP与caspase-9的结合以及ML-IAP、cIAP1、cIAP2与Smac的联系，从而起到抑制作用。

Specs ⸢ View details ⸥

Chinese name

GDC-0152, 含 2 的杆状病毒 IAP 重复序列拮抗剂

English name

GDC-0152

Chinese alias

English alias

AC-32972 | Z2235802113 | A14135 | L-PROLINAMIDE, N-METHYL-L-ALANYL-(2S)-2-CYCLOHEXYLGLYCYL-N-(4-PHENYL-1,2,3-THIADIAZOL-5-YL)- | A916910 | EX-A1658 | Q27077778 | SCHEMBL10166489 | UNII-4KW1M48SHS | 873652-48-3 (free base) | Tox21_300414 | SW220303-1 | S70

CAS number

873652-48-3

molecular formula

C25H34N6O3S

molecular weight

498.64 g/mol

Exact mass

PSA

145.000 Å²

Logp

3.400

Technical Documents

「No technical documents」

「No upstream and downstream information yet」

Articles

「No related articles yet」

user reviews

Consultation

Warm reminder：

Because the manufacturer may temporarily adjust product specifications, prices, inventory, parameters and other information without notice, and there are differences in each user's consultation time and procurement needs, the platform reply content is only of reference value within a certain period. Sorry for the inconvenience caused to you, and thank you for your understanding and support! Please consult the online customer service for the latest details. Everything is subject to the real-time reply of the customer service.！

After Sales Services

Please check the quantity, appearance and product information in time when you receive the goods. In case of damage, wrong delivery, abnormal quality and other problems, please feel free to contact us.

Service Hotline:400-6226-992 ，We will handle it for you as soon as possible, thank you for your support and trust.！